grant

Society for Inherited Metabolic Disorders Annual Meeting

Organization BOSTON CHILDREN'S HOSPITALLocation BOSTON, UNITED STATESPosted 1 Jun 2022Deadline 30 Nov 2027
NIHUS FederalResearch GrantFY2026AffectAmericanAreaArthritisAwardBlindnessCardiac DiseasesCardiac DisordersCaringCerebral PalsyCitiesClinicalClinical TrialsClinical geneticsCongressesDevelopmentDiabetes MellitusDiseaseDisorderDrugsEnzyme GeneEnzymesFailureFundingGeneralized GrowthGenerationsGenesGeneticGoalsGrantGrowthHeart DiseasesHepaticHereditaryHereditary Metabolic DisorderInborn Errors of MetabolismIndividualInheritedIntellectual disabilityIntellectual functioning disabilityIntellectual limitationInternationalInvestigatorsJapanKnowledgeMass Photometry/Spectrum AnalysisMass SpectrometryMass SpectroscopyMass SpectrumMass Spectrum AnalysesMass Spectrum AnalysisMedical GeneticsMedicationMetabolicMetabolic DiseasesMetabolic DisorderMolecularNational Institutes of HealthNeonatal ScreeningNeuromuscular DiseasesNewborn Infant ScreeningPathway interactionsPatient CarePatient Care DeliveryPharmaceutical PreparationsPhysiciansPrivatizationQualifyingRecruitment ActivityResearchResearch PersonnelResearchersScholarshipSocietiesSodium ChlorideSourceThesaurismosisTissue GrowthTrainingTravelUnited StatesUnited States National Institutes of HealthVariantVariationactive recruitmentarthriticcare for patientscare of patientscaring for patientscostdesigndesigningdetermine efficacydevelopmentaldiabetesdrug/agenteffective therapyeffective treatmentefficacy analysisefficacy assessmentefficacy determinationefficacy evaluationefficacy examinationentire genomeevaluate efficacyexamine efficacyexomefull genomegenome sequencingheart disorderinborn metabolism disorderintellectual and developmental disabilitykidney dysfunctionlimited intellectual functioningmedical collegemedical schoolsmeetingmeetingsmetabolism disordermyoneural disorderneuromuscular degenerative disorderneuromuscular disordernew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynewborn screeningnext generation therapeuticsnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyontogenypathwayrenal dysfunctionsaltschool of medicinescreening programvision lossvisual losswhole genome
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

ABSTRACT
The Society for Inherited Metabolic Disorders (SIMD) requests support to provide scholarships for trainees to attend its annual meetings in years 2023 to 2027. The 2022 meeting will be held in Orlando, FL April 10-13, 2022. The 2022 meeting will be supported by no-cost extension of the previous grant. The 2023 meeting will be held in Salt Lake City, UT March 18-21, 2023 in conjunction with the American College of Medical Genetics (ACMG) following their meeting. The 2024 meeting is TBD. The 2025 meeting will be held in conjunction with the International Congress on Inborn Errors of Metabolism in Kyoto, Japan. The 2026 meeting is TBD. The 2027 meeting is TBD.

Inborn errors of metabolism (IEM) are an important cause of intellectual disability, cerebral palsy, neuromuscular disease, cardiac disorders, hepatic and renal dysfunction, arthritis, diabetes, growth failure and blindness. As the wide clinical and molecular spectrum of these disorders is being elucidated, in part fueled by the development of tandem mass spectroscopy and the rapid expansion of newborn screening programs, the number of affected individuals is now known to be much larger than originally recognized. In addition, therapies are available for some conditions, but few clinical trials have been performed to evaluate their efficacy. Thus, much remains to be done to better understand these severe disorders and develop effective treatments for them.

For the U.S. to remain pre-eminent in this important area of research, it is essential to attract young investigators into the field. One effective mechanism to achieve this goal is to provide them with the opportunity to participate in the SIMD meeting, where they can explore the field and develop scientific ties to other established investigators. The SIMD meeting is held annually and participation, especially by young investigators, has been steadily increasing each year. The availability of NIH travel awards has been a major reason for this increase.

Trainees seeking funding are required to submit an abstract describing original research to be presented at the meeting. We anticipate submission of 40 abstracts for presentation at each meeting from trainees/young investigators with twice that number for the international meeting (2025). Applications for travel awards will be competitively reviewed 4 months prior to each meeting, with the goal of making up 10 annual awards of $1,000 each for the national meeting and up to 5 awards of $2,000 for the International meeting. Additional funds will be solicited from private sources.

All applicants will be actively recruited.

Grant Number: 5R13HD108942-04
NIH Institute/Center: NIH

Principal Investigator: Gerard Berry

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →